News & Updates

Administering corticosteroids during pregnancy leads to improved postnatal growth in infants born extremely or very preterm, as shown in a study.

Surgical-trauma patients with open abdomen administered with intravenous crystalloid appear to have the shortest time to abdomen closure relative to those who received bolus or continuous albumin, a recent study has shown.

Infants treated with darbepoetin through 35 weeks’ postmenstrual age (PMA) have a lower risk of death or grade 2‒3 bronchopulmonary dysplasia (BPD) and a reduced duration of exposure to positive airway pressure, reports a study presented at PAS 2024.

Adverse drug events commonly occur in the outpatient setting and are often serious, a study has shown. In addition, adverse event (AE) rates are greater in older adults.

In the second-line treatment of patients with metastatic colorectal cancer harbouring KRAS mutation, onvansertib combined with FOLIFRI/bevacizumab demonstrates promising clinical activity while having a manageable safety profile, according to the results of a phase Ib study.

In people with rheumatic and musculoskeletal diseases (RMDs), inactivated COVID-19 vaccines prove safe and effective at lowering the risk of COVID-19–related pneumonia, as shown in a study from China.

The plant-based alkaloid cytisinicline, when coupled with behavioural support, shows promise in the treatment of e-cigarette users who seek to break the habit.